Your browser doesn't support javascript.
loading
Acalabrutinib as a novel hope for the treatment of breast and lung cancer: an in-silico proof of concept.
Khaparkhuntikar, Kedar; Maji, Indrani; Gupta, Sunil Kumar; Mahajan, Srushti; Aalhate, Mayur; Sriram, Anitha; Gupta, Ujala; Guru, Santosh Kumar; Kulkarni, Prachi; Singh, Pankaj Kumar.
Afiliación
  • Khaparkhuntikar K; Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India.
  • Maji I; Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India.
  • Gupta SK; Department of Bioinformatics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India.
  • Mahajan S; Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India.
  • Aalhate M; Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India.
  • Sriram A; Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India.
  • Gupta U; Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India.
  • Guru SK; Department of Biological Science, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India.
  • Kulkarni P; Department of Physiology, Shri B. M. Patil Medical College, Hospital & Research Centre BLDE (Deemed to be University), Vijayapura, Karnataka, India.
  • Singh PK; Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India.
J Biomol Struct Dyn ; 42(3): 1469-1484, 2024.
Article en En | MEDLINE | ID: mdl-37272883

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Pirazinas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Idioma: En Revista: J Biomol Struct Dyn Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Pirazinas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Idioma: En Revista: J Biomol Struct Dyn Año: 2024 Tipo del documento: Article